Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.
about
Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer riskChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trialIndividual patient data meta-analysis in cancer.Role of chemotherapy in Hodgkin's lymphoma.Role of Radiotherapy in Modern Treatment of Hodgkin's LymphomaPrognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography.Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites.Approach to Hodgkin's lymphoma in the new millennium.Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.The Management of Classical Hodgkin's Lymphoma: Past, Present, and FutureThe benefit of consolidation radiotherapy to initial disease bulk in patients with advanced Hodgkin's disease who achieved complete remission after standard chemotherapyRadiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-upClinical Profile and Chemotherapy Response in Children with Hodgkin Lymphoma at a Tertiary Care CentreSEOM clinical guidelines for the treatment of Hodgkin's lymphoma.Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trialsPositron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphomaClassical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-upRisk-adapted strategies for the treatment of Hodgkin lymphoma.Patterns of care and survival outcomes examining radiation therapy for advanced Hodgkin lymphoma.Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).Advanced Hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy: a study of 82 patients from the Groupes d'Etudes des Lymphomes de l'Adulte H89 tTreatment of patients with advanced or bulky Hodgkin disease with a 12-week doxorubicin, bleomycin, vinblastine, and dacarbazine-like chemotherapy regimen followed by extended-field, full-dose radiotherapy: long-term results of the Groupe Ouest et ETreatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.The German evidence-based guidelines for Hodgkin's lymphoma. Aspects for radiation oncologists.
P2860
Q24245375-E3747B90-8778-40FE-BC4E-EF77D55C9D95Q28365255-44CC6F8F-DC3D-480B-8206-8516092619B7Q32053086-3A0BFE20-EA76-4AFD-A81A-D5BCC468F434Q33761103-E18C59F8-A5E1-4D1A-B073-7CC91BE77F3BQ34235785-8FB12371-2A9F-409C-9EEA-DC7DCF89D459Q34495333-61CF1CC5-C3BB-4A1B-8068-B1DAA33E5B08Q34548300-DC26900F-C4BE-4473-BA16-9375F1C5A2E1Q34580600-4A094369-3935-4AFD-A4D0-C9238C6B6E04Q34610653-0E2A84F1-8040-4BA6-AC9C-C9DE09291196Q35038852-F5D59F7F-F154-4DF5-A3C2-5D1E10899F94Q35219755-A253195D-E411-4C40-BA0A-7CDB04520A80Q35892254-244A6C2F-515F-44AB-87A8-D3AA39794823Q36343717-4E7E01CC-0F2E-4FCD-B674-00E2385ECDA5Q36400264-A8FD0FB3-D933-4104-BD12-9AB0552631B1Q36589635-E64D4C50-4546-4E1D-A240-6B771B270B59Q36969748-E02C898A-5241-4860-84FA-5CEA266CDC40Q37146056-009A4239-4157-4EFC-B878-CBD05903F0F9Q38591137-754A114D-388A-4069-A4F4-0F808DE57A2CQ39658515-BD82C6A5-6ACC-48DB-B86B-063F9970748AQ40044179-CA76EA0F-C845-49E7-9A64-4ECA582D0AF3Q40712492-335BF225-7CF0-4FBE-AC07-1F38E851AD7EQ43707347-F48C142E-8D7C-409F-ADE1-7B643096C50FQ44202170-D045011B-24A3-4374-9948-605E2F4ED525Q44916266-8A56F8E1-C791-43AD-BA27-06B5FD981CEEQ53112256-7D298D2B-CCB4-44B3-87D9-1FA3E615128B
P2860
Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Meta-analysis of chemotherapy ...... Disease Overview Study Group.
@ast
Meta-analysis of chemotherapy ...... Disease Overview Study Group.
@en
Meta-analysis of chemotherapy ...... Disease Overview Study Group.
@nl
type
label
Meta-analysis of chemotherapy ...... Disease Overview Study Group.
@ast
Meta-analysis of chemotherapy ...... Disease Overview Study Group.
@en
Meta-analysis of chemotherapy ...... Disease Overview Study Group.
@nl
prefLabel
Meta-analysis of chemotherapy ...... Disease Overview Study Group.
@ast
Meta-analysis of chemotherapy ...... Disease Overview Study Group.
@en
Meta-analysis of chemotherapy ...... Disease Overview Study Group.
@nl
P2093
P1476
Meta-analysis of chemotherapy ...... Disease Overview Study Group.
@en
P2093
A A Bartolucci
D Assouline
D Crowther
D Hasenclever
E Thompson
M Loeffler
O Brosteanu
P A Cassileth
P304
P356
10.1200/JCO.1998.16.3.818
P407
P577
1998-03-01T00:00:00Z